Skip to main content
Livermore
Livermore
ZHEN

Wealthfront Advisers LLC

SEC CIK
0001763921
Latest filing
Aug 7, 2026

ELV holding history

Elevance Health, Inc. in every 13F filed by Wealthfront Advisers LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ELV overviewAll 13F holders of ELVFull Q2 2026 holdings

Shares (Q2 2026)
22,226
Value
$8.60M
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of ELV by Wealthfront Advisers LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202622,226$8.60M<0.1%−11,629−34.3%ReducedHolders
Q1 202633,855$9.91M<0.1%−10,217−23.2%ReducedHolders
Q4 202544,072$15.4M<0.1%+9,030+25.8%AddedHolders
Q3 202535,042$11.3M<0.1%+19,292+122.5%AddedHolders
Q2 202515,750$6.13M<0.1%+2,042+14.9%AddedHolders
Q1 202513,708$5.96M<0.1%+7,400+117.3%AddedHolders
Q4 20246,308$2.33M<0.1%−7,006−52.6%ReducedHolders
Q3 202413,314$6.92M<0.1%−941−6.6%ReducedHolders
Q2 202414,255$7.72M<0.1%+254+1.8%AddedHolders
Q1 202414,001$7.26M<0.1%−400−2.8%ReducedHolders
Q4 202314,401$6.79M<0.1%+3,345+30.3%AddedHolders
Q3 202311,056$4.81M<0.1%−1,224−10.0%ReducedHolders
Q2 202312,280$5.46M<0.1%−4,144−25.2%ReducedHolders
Q1 202316,424$7.55M<0.1%−6,490−28.3%ReducedHolders
Q4 202222,914$11.8M0.1%+1,740+8.2%AddedHolders
Q3 202221,174$9.62M0.1%−736−3.4%ReducedHolders
Q2 202221,910$10.6M0.1%+2,642+13.7%AddedHolders
Q1 202219,268$9.46M<0.1%+5,340+38.3%AddedHolders
Q4 202113,928$6.46M<0.1%+46+0.3%AddedHolders
Q3 202113,882$5.17M<0.1%+6,476+87.4%AddedHolders
Q2 20217,406$2.83M<0.1%+1,153+18.4%AddedHolders
Q1 20216,253$2.25M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.